Tracking unruptured brain aneurysms over three years
Part of Brain & nervous system clinical trials.
This study follows adults with a small, unruptured brain aneurysm to better predict how it may change over time. It may help doctors estimate which aneurysms are more likely to worsen and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You have a brain aneurysm that has not ruptured and does not cause symptoms
- Your aneurysm is between 3 and 7 mm at its largest part, and is a common type at a branch point
- You have no treatment for the aneurysm yet (untreated) and it was seen on imaging (MRI, CT angiography, or catheter angiography)
- You can be followed for about 3 years
- You must be able to have MRI scans, including (if needed) a contrast dye
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two approaches for people with a small, unruptured brain aneurysm: careful monitoring over time versus treating it right away with a procedure. The goal is to learn which option is safer and helps prevent future bleeding.
This study uses MRI scans to track how brain aneurysms that haven't bled change over time. It may help doctors understand which aneurysms are most likely to grow.
This study looks at whether having extra check-ins with health professionals (like nurses or therapists) can help people living with an unruptured brain aneurysm. If you have a newly found or monitored aneurysm and no history of a rupture, you may be able to join.
This trial tests a new device to block blood flow into unruptured brain aneurysms (balloon-like bulges). It is for adults whose aneurysm has not bled and fits specific size requirements. The goal is to see if the device is safe and works well.
This trial tests a new device, called LuSeed, for treating brain aneurysms that haven't burst. The device is placed inside the aneurysm to block blood flow and prevent rupture. The study aims to see if the device is safe and works well in patients with a specific type of aneurysm.
This trial looks at tiny particles in the blood called extracellular vesicles to see how they differ in patients with brain aneurysms. It may help doctors better understand these aneurysms and improve treatment.
Hear when a new Unruptured Intracranial Aneurysm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.